Back to results
US 2025/0051339 A1Published application
Methods for the synthesis of complement factor d inhibitors
AssigneeAlexion Pharmaceuticals, Inc.
InventorAkihiro Hashimoto
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods for the synthesis of complement factor D inhibitors and intermediates thereof. The methods involve subjecting an intermediate in the synthesis of a complement factor D inhibitor to a t-butyl ester deprotection reaction using a weak base.
Claims135
A method of preparing a compound of formula (I), comprising reacting a compound of formula (II) with a weak base in a water-miscible organic solvent:
- wherein
- R1 is H;
- halo;
- OH;
- NH2;
- cyano;
- optionally substituted C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted 3- to 8-membered heterocyclyl;
- —C(O)NRaRa′, wherein each of Ra and Ra′ is, independently, H, optionally substituted C1-C6 alkyl, optionally substituted C2-C6 alkenyl, optionally substituted C2-C6 alkynyl, or optionally substituted C3-C8 cycloalkyl;
- —C(O)Rb;
- —OC(O)Rb;
- or —C(O)ORb;
- wherein Rb, in each instance, is selected from H, optionally substituted C1-C6 alkyl, optionally substituted C1-C6 alkoxy, and optionally substituted C3-C8 carbocyclyl;
- each of R2 and R3 is, independently, H or optionally substituted C1-C6 alkyl;
- X1 is N or CRc, wherein Rc is H, halo, optionally substituted C1-C6 alkyl, or optionally substituted C1-C6 alkoxy;
- each of X2 and X5 is independently N or CRd, wherein each Rd is independently selected from H, halo, cyano, optionally substituted C1-C6 alkyl, optionally substituted C1-C6 alkoxy, optionally substituted C3-C8 carbocyclyl, and optionally substituted 5- to 8-membered heteroaryl;
- and
- each of X3 and X4 is independently selected from N, CRe, and CRf, wherein Re is selected from H, halo, cyano, optionally substituted C1-C6 alkyl, optionally substituted C1-C6 alkoxy, and —C(O)ORg, wherein Rg is H or optionally substituted C1-C6 alkyl;
- and Rf is selected from optionally substituted C4-C10 aryl, optionally substituted 5- to 10-membered heteroaryl containing 1, 2, or 3 heteroatoms selected from N, O, and S, and optionally substituted 4- to 10-membered saturated or unsaturated non-aromatic heterocyclyl containing 1-4 heteroatoms selected from N, O, and S;
- wherein at least one of X3 and X4 is CRf.
18 more elements
Dependencies are inferred from the claim text.